HomeAPRE • NASDAQ
Aprea Therapeutics Inc
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 205.82K | 1,362.29% |
Operating expense | 1.07M | -34.72% |
Net income | -2.89M | 15.93% |
Net profit margin | -1.41K | 94.25% |
Earnings per share | -0.49 | 46.74% |
EBITDA | -3.22M | 12.24% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.85M | 5.75% |
Total assets | 23.98M | 5.87% |
Total liabilities | 3.36M | -23.36% |
Total equity | 20.62M | — |
Shares outstanding | 5.49M | — |
Price to book | 0.51 | — |
Return on assets | -31.71% | — |
Return on capital | -36.76% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.89M | 15.93% |
Cash from operations | -3.51M | 6.12% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 134.41K | — |
Net change in cash | -3.40M | 9.22% |
Free cash flow | -2.65M | -1.04% |
Previous close
$1.80
Day range
$1.67 - $1.85
Year range
$1.67 - $6.48
Market cap
9.34M USD
Avg Volume
21.67K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Website
Employees
8
